Skip to main content

Advertisement

SpringerLink
Log in

Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

Osteosarcoma is the most common primary malignancy in orthopaedic surgery. Studies suggest that expression of VEGF and high vascularity within osteosarcoma may correlate with poor prognosis. The purpose of this study was to determine whether there was a correlation of VEGF expression with clinical tumour stage and metastasis.

Methods

This retrospective case series examined 54 cases of osteosarcoma patients who were treated during a ten-year period. Relevant clinical information included age, gender, tumour location, stage, adjuvant therapy, morbidity, mortality, and tumour subtypes. The clinical information was analysed for correlation of VEGF expression and tumour prognosis. Tumour sections were examined by routine H&E and by immunohistochemistry for VEGF, CD31, and the oncogenes c-myc and c-fos.

Results

There was a significantly positive correlation between VEGF expression and tumour stages among these cases (p < 0.01). The data also suggested a higher cancer recurrence and more frequent cases of remote metastasis in the high-VEGF group compared to the low-VEGF group. VEGF expression also positively associated with c-fos and c-myc expressions in the primary tumour sections.

Conclusion

The results of this study highlight the role of VEGF in angiogenesis and tumour burden. Data also suggest the influence of VEGF may associate with the elevations of c-fos and c-myc expression. The development of novel therapies to target the VEGF pathway in osteosarcoma may lead to improved survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Messerschmitt PJ, Garcia RM, Abdul-Karim FW, Greenfield EM, Getty PJ (2009) Osteosarcoma. J Am Acad Orthop Surg 17(8):515–527

    PubMed  Google Scholar 

  2. Rosen G, Suwansirikul S, Kwon C, Tan C, Wu SJ, Beattie EJ Jr, Murphy ML (1974) High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer 33(4):1151–1163

    Article  PubMed  CAS  Google Scholar 

  3. Coomber BL, Denton J, Sylvestre A, Kruth S (1998) Blood vessel density in canine osteosarcomas. Can J Vet Res 62(3):199–204

    PubMed  CAS  Google Scholar 

  4. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246(4935):1309–1312

    Article  PubMed  CAS  Google Scholar 

  5. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246(4935):1306–1309

    Article  PubMed  CAS  Google Scholar 

  6. Sallinen H, Anttila M, Narvainen J, Koponen J, Hamalainen K, Kholova I, Heikura T, Toivanen P, Kosma VM, Heinonen S, Alitalo K, Yla-Herttuala S (2009) Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice. Mol Ther 17(2):278–284. doi:10.1038/mt.2008.258

    Article  PubMed  CAS  Google Scholar 

  7. Jia ZZ, Jiang GM, Feng YL (2011) Serum HIF-1alpha and VEGF levels pre- and post-TACE in patients with primary liver cancer. Chin Med Sci J (Chung-kuo i hsueh k'o hsueh tsa chih/Chinese Academy of Medical Sciences) 26(3):158–162

    CAS  Google Scholar 

  8. Roland CL, Dineen SP, Lynn KD, Sullivan LA, Dellinger MT, Sadegh L, Sullivan JP, Shames DS, Brekken RA (2009) Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts. Mol Cancer Ther 8(7):1761–1771. doi:10.1158/1535-7163.MCT-09-0280

    Article  PubMed  CAS  Google Scholar 

  9. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N, Nakamura M (1998) Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77(6):998–1002

    Article  PubMed  CAS  Google Scholar 

  10. Yuan A, Yu CJ, Kuo SH, Chen WJ, Lin FY, Luh KT, Yang PC, Lee YC (2001) Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol 19(2):432–441

    PubMed  CAS  Google Scholar 

  11. Lee YH, Tokunaga T, Oshika Y, Suto R, Yanagisawa K, Tomisawa M, Fukuda H, Nakano H, Abe S, Tateishi A, Kijima H, Yamazaki H, Tamaoki N, Ueyama Y, Nakamura M (1999) Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 35(7):1089–1093

    Article  PubMed  CAS  Google Scholar 

  12. Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, Higashino F, Mezawa F, Okada F, Ishii S (2000) Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 6(2):572–577

    PubMed  CAS  Google Scholar 

  13. Ben Josef E, Yang SY, Ji TH, Bidart JM, Garde SV, Chopra DP, Porter AT, Tang DG (1999) Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR). J Urol 161(3):970–976

    Article  PubMed  CAS  Google Scholar 

  14. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1(1):27–31

    Article  PubMed  CAS  Google Scholar 

  15. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143(2):401–409

    PubMed  CAS  Google Scholar 

  16. Weidner N, Folkman J (1996) Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol 167–190

  17. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86(3):353–364

    Article  PubMed  CAS  Google Scholar 

  18. McMahon G (2000) VEGF receptor signaling in tumor angiogenesis. Oncologist 5(Suppl 1):3–10

    Article  PubMed  CAS  Google Scholar 

  19. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(6 Suppl 16):15–18

    PubMed  CAS  Google Scholar 

  20. Suzuki K, Hayashi N, Miyamoto Y, Yamamoto M, Ohkawa K, Ito Y, Sasaki Y, Yamaguchi Y, Nakase H, Noda K, Enomoto N, Arai K, Yamada Y, Yoshihara H, Tujimura T, Kawano K, Yoshikawa K, Kamada T (1996) Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 56(13):3004–3009

    PubMed  CAS  Google Scholar 

  21. Cole MD, McMahon SB (1999) The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18(19):2916–2924

    Article  PubMed  CAS  Google Scholar 

  22. van den Berg S, Rahmsdorf HJ, Herrlich P, Kaina B (1993) Overexpression of c-fos increases recombination frequency in human osteosarcoma cells. Carcinogenesis 14(5):925–928

    Article  PubMed  Google Scholar 

  23. Wu JX, Carpenter PM, Gresens C, Keh R, Niman H, Morris JW, Mercola D (1990) The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene 5(7):989–1000

    PubMed  CAS  Google Scholar 

  24. Gamberi G, Benassi MS, Bohling T, Ragazzini P, Molendini L, Sollazzo MR, Pompetti F, Merli M, Magagnoli G, Balladelli A, Picci P (1998) C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology 55(6):556–563

    Article  PubMed  CAS  Google Scholar 

  25. Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ, Pass HI, Picci P, Levine AS, Carbone M (1996) Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem 63(1):37–50

    Article  PubMed  CAS  Google Scholar 

  26. Takayama K, Ueno H, Nakanishi Y, Sakamoto T, Inoue K, Shimizu K, Oohashi H, Hara N (2000) Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. Cancer Res 60(8):2169–2177

    PubMed  CAS  Google Scholar 

  27. Yang SY, Yu H, Krygier JE, Wooley PH, Mott MP (2007) High VEGF with rapid growth and early metastasis in a mouse osteosarcoma model. Sarcoma 2007:95628

    Article  PubMed  Google Scholar 

  28. Yin D, Jia T, Gong W, Yu H, Wooley PH, Mott MP, Yang SY (2008) VEGF blockade decelerates the growth of a murine experimental osteosarcoma. Int J Oncol 33(2):253–259

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Kansas School of Medicine-Wichita, Wichita, KS, USA

    John Lammli, Meghan Patni, Elizabeth Rinehart, Elizabeth Ablah, Paul H. Wooley, George Lucas & Shang-You Yang

  2. Biological Sciences, Wichita State University, Wichita, KS, USA

    Minyan Fan, Paul H. Wooley & Shang-You Yang

  3. Mid-America Sarcoma Institute, Overland Park, KS, USA

    Howard G. Rosenthal & Gerardo Vergara

  4. Orthopaedic Research Institute, Via Christi Health System, 929 N St Francis Street, Wichita, KS, 67214, USA

    Paul H. Wooley & Shang-You Yang

Authors
  1. John Lammli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Minyan Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Howard G. Rosenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meghan Patni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elizabeth Rinehart
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gerardo Vergara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elizabeth Ablah
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Paul H. Wooley
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. George Lucas
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shang-You Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shang-You Yang.

Additional information

Meghan Patni and Elizabeth Rinehart contributed equally in this study

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lammli, J., Fan, M., Rosenthal, H.G. et al. Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma. International Orthopaedics (SICOT) 36, 2307–2313 (2012). https://doi.org/10.1007/s00264-012-1629-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-012-1629-z

Keywords

Search

Navigation